{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T22:35:10Z","timestamp":1775687710667,"version":"3.50.1"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0114121","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T21:06:15Z","timestamp":1417467975000},"page":"e114121","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Growth Inhibition of Head and Neck Squamous Cell Carcinoma Cells by sgRNA Targeting the Cyclin D1 mRNA Based on TRUE Gene Silencing"],"prefix":"10.1371","volume":"9","author":[{"given":"Satoshi","family":"Iizuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Oridate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Nashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"A Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"A Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"M Malumbres","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"EA Musgrove","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1038\/sj.onc.1202153","article-title":"Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification","volume":"17","author":"JG Izzo","year":"1998","journal-title":"Oncogene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc2771","article-title":"A census of amplified and overexpressed human cancer genes","volume":"10","author":"T Santarius","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"ref7","first-page":"2810","article-title":"Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue","volume":"5","author":"RJ Bova","year":"1999","journal-title":"Clin Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1368-8375(99)00078-0","article-title":"Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma","volume":"36","author":"H Mineta","year":"2000","journal-title":"Oral Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1158\/1078-0432.CCR-03-0751","article-title":"Cyclin D1, p53, and p21Waf1\/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer","volume":"10","author":"A Bali","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.0959-9673.2005.00447.x","article-title":"Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma","volume":"86","author":"GR Thomas","year":"2005","journal-title":"Int J Exp Pathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"P Jares","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1258\/00222150360600896","article-title":"Distribution and prognostic significance of cell cycle proteins in squamous carcinoma of the larynx, hypopharynx and adjacent epithelial hyperplastic lesions","volume":"117","author":"M Volavsek","year":"2003","journal-title":"J Laryngol Otol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/hed.20632","article-title":"Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy","volume":"29","author":"E Higuchi","year":"2007","journal-title":"Head Neck"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00280-009-0968-y","article-title":"A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI), in patients with advanced solid tumours","volume":"64","author":"EN Scott","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrc1974","article-title":"mTOR and cancer: insights into a complex relationship","volume":"6","author":"DM Sabatini","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/nar\/26.11.2565","article-title":"RNA heptamers that direct RNA cleavage by mammalian tRNA 3\u2032 processing endoribonuclease","volume":"26","author":"M Nashimoto","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-5793(00)01462-9","article-title":"Anomalous RNA substrates for mammalian tRNA 3\u2032 processing endoribonuclease","volume":"472","author":"M Nashimoto","year":"2000","journal-title":"FEBS Lett"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1093\/nar\/gkg641","article-title":"Intracellular mRNA cleavage by 3\u2032 tRNase under the direction of 2\u2032-O-methyl RNA heptamers","volume":"31","author":"M Tamura","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/nar\/gnh092","article-title":"A novel 4-base-recognizing RNA cutter that can remove the single 3\u2032 terminal nucleotides from RNA molecules","volume":"32","author":"H Takaku","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"22326","DOI":"10.1074\/jbc.M502048200","article-title":"The T loop structure is dispensable for substrate recognition by tRNase ZL","volume":"280","author":"HS Shibata","year":"2005","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.bbrc.2008.12.173","article-title":"Inhibition of vascular endothelial growth factor expression by TRUE gene silencing","volume":"379","author":"R Elbarbary","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/sj.gt.3302841","article-title":"Gene silencing by the tRNA maturase tRNase Z(L) under the direction of small-guide RNA","volume":"14","author":"A Nakashima","year":"2007","journal-title":"Gene Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bbrc.2011.11.091","article-title":"Expanding the utility of heptamer-type sgRNA for TRUE gene silencing","volume":"416","author":"T Sano","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.canlet.2012.10.016","article-title":"A naked RNA heptamer targeting the human Bcl-2 mRNA induces apoptosis of HL60 leukemia cells","volume":"328","author":"M Takahashi","year":"2013","journal-title":"Cancer Letters"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.leukres.2013.01.015","article-title":"Induction of apoptosis of leukemic cells by TRUE gene silencing using small guide RNAs targeting the WT1 mRNA","volume":"37","author":"N Watanabe","year":"2013","journal-title":"Leuk Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.leukres.2014.03.021","article-title":"Screening of a heptamer-type sgRNA library for potential therapeutic agents against hematological malignancies","volume":"38","author":"M Takahashi","year":"2014","journal-title":"Leuk Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-0714.1989.tb01570.x","article-title":"Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas","volume":"18","author":"F Momose","year":"1989","journal-title":"J Oral Pathol Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.97.5.695","article-title":"Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix","volume":"97","author":"WF Scherer","year":"1953","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/AAC.12.1.11","article-title":"Human interferon: mass production in a newly established cell line, MG-63","volume":"12","author":"A Billiau","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2443.2008.01258.x","article-title":"Bone morphogenetic protein-2 enhances Wnt\/beta-catenin signaling-induced osteoprotegerin expression","volume":"14","author":"M Sato","year":"2009","journal-title":"Genes Cells"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2007.12.033","article-title":"Visualizing spatiotemporal dynamics of multicellular cell-cycle progression","volume":"132","author":"A Sakaue-Sawano","year":"2008","journal-title":"Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ncb1038","article-title":"Activation of the interferon system by short-interfering RNAs","volume":"5","author":"CA Sledz","year":"2003","journal-title":"Nat Cell Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/35082500","article-title":"Specific protection against breast cancers by cyclin D1 ablation","volume":"411","author":"Q Yu","year":"2001","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cell.2004.07.025","article-title":"Mouse development and cell proliferation in the absence of D-cyclins","volume":"118","author":"K Kozar","year":"2004","journal-title":"Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/369669a0","article-title":"Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice","volume":"369","author":"TC Wang","year":"1994","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/gyno.1998.5062","article-title":"Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines","volume":"70","author":"M Cagnoli","year":"1998","journal-title":"Gynecol Oncol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1006\/bbrc.1996.0470","article-title":"Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression","volume":"220","author":"WC Hung","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"ref38","first-page":"131","article-title":"Inhibition of lung cancer proliferation by antisense cyclin D","volume":"3","author":"DS Schrump","year":"1996","journal-title":"Cancer Gene Ther"},{"key":"ref39","first-page":"L941","article-title":"Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth","volume":"273","author":"B Driscoll","year":"1997","journal-title":"Am J Physiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0194-5998(98)70017-8","article-title":"Inhibition of cell proliferation in head and neck squamous cell carcinoma cell lines with antisense cyclin D1","volume":"119","author":"MB Wang","year":"1998","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref41","first-page":"4876","article-title":"Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas","volume":"59","author":"ER Sauter","year":"1999","journal-title":"Cancer Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1172\/JCI1323","article-title":"Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum","volume":"101","author":"M Kornmann","year":"1998","journal-title":"J Clin Invest"},{"key":"ref43","first-page":"1569","article-title":"Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells","volume":"57","author":"N Arber","year":"1997","journal-title":"Cancer Res"},{"key":"ref44","first-page":"571","article-title":"Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells","volume":"11","author":"P Zhou","year":"1995","journal-title":"Oncogene"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4161\/cbt.4.3.1504","article-title":"Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting eIF4E or cyclin D1 alone or combined with cisplatin","volume":"4","author":"N Oridate","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1093\/nar\/gkp841","article-title":"Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents","volume":"38","author":"CA Stein","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/CIRCULATIONAHA.105.606442","article-title":"Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B","volume":"114","author":"JJ Kastelein","year":"2006","journal-title":"Circulation"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nbt759","article-title":"Systemically delivered antisense oligomers upregulate gene expression in mouse tissues","volume":"20","author":"P Sazani","year":"2002","journal-title":"Nat Biotechnol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.4049\/jimmunol.176.6.3652","article-title":"Modification of MyD88 mRNA splicing and inhibition of IL-1beta signaling in cell culture and in mice with a 2\u2032-O-methoxyethyl-modified oligonucleotide","volume":"176","author":"TA Vickers","year":"2006","journal-title":"J Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1093\/nar\/gkr089","article-title":"Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes","volume":"39","author":"E Koller","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1073\/pnas.86.10.3474","article-title":"Characterization of oligonucleotide transport into living cells","volume":"86","author":"SL Loke","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1093\/nar\/22.20.4268","article-title":"Patterns of intracellular compartmentalization, trafficking and acidification of 5\u2032-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells","volume":"22","author":"JL Tonkinson","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"ZH Siddik","year":"2003","journal-title":"Oncogene"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0114121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T04:39:51Z","timestamp":1588999191000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0114121"}},"subtitle":[],"editor":[{"given":"Muy-Teck","family":"Teh","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":53,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0114121","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,1]]}}}